Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019

Markos Kalligeros1, Fadi Shehadeh1, Evangelia K Mylona1

  • 1Infectious Diseases Division, Warren Alpert Medical School, Brown University-Rhode Island Hospital, Providence, Rhode Island, USA.

Insights

Severe obesity (BMI ≥ 35 kg/m²) increased intensive care unit admission risk in COVID-19 patients. Obesity and heart disease were linked to invasive mechanical ventilation needs.

Area of Science:

  • Medical Research
  • Epidemiology
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) poses significant health risks.
  • Obesity and chronic diseases are potential risk factors for severe COVID-19 outcomes.

Purpose of the Study:

  • To investigate the association between obesity and chronic conditions with severe COVID-19 outcomes.
  • To determine the risk of intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) in hospitalized COVID-19 patients with obesity.

Main Methods:

  • Retrospective cohort study of 103 hospitalized COVID-19 patients.
  • Analysis of demographic data, medical history, and hospital course.
  • Multivariate logistic regression to identify independent risk factors.

Main Results:

  • Obesity prevalence was 47.5% among hospitalized patients.
  • Severe obesity (BMI ≥ 35 kg/m²) was associated with ICU admission (aOR: 5.39).
  • Heart disease, obesity (BMI 30-34.9 kg/m²), and severe obesity were linked to IMV requirement.

Conclusions:

  • Severe obesity is a significant risk factor for ICU admission in COVID-19.
  • Obesity and heart disease independently predict the need for IMV.
  • Heightened vigilance and proactive management are crucial for COVID-19 patients with obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
162
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
180
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K